Provided by Tiger Trade Technology Pte. Ltd.

Meiragtx Holdings Plc

14.34
-0.2000-1.38%
Post-market: 14.340.00000.00%19:30 EDT
Volume:635.48K
Turnover:9.12M
Market Cap:1.38B
PE:15.28
High:14.85
Open:14.70
Low:14.10
Close:14.54
52wk High:15.35
52wk Low:6.62
Shares:96.04M
Float Shares:53.68M
Volume Ratio:0.73
T/O Rate:1.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9383
EPS(LYR):-1.4199
ROE:72.17%
ROA:38.65%
PB:6.39
PE(LYR):-10.10

Loading ...

MeiraGTx CEO Alexandria Forbes Sells 62,000 Shares for $859,320

Reuters
·
Aug 19

Profit Surge and New Leadership Might Change The Case For Investing In MeiraGTx Holdings (MGTX)

Simply Wall St.
·
Aug 16

Emmaus Life Sciences Q2 Revenue Soars on Licensing Deal

Reuters
·
Aug 15

Inflammation Drug Developer HCW Biologics' Q2 Net Loss Widens

Reuters
·
Aug 15

MeiraGTx Seen Nearing First Commercial Launches as Key Programs Advance, RBC Says

MT Newswires Live
·
Aug 15

RBC Adjusts PT on MeiraGTx to $27 From $26, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 14

Bank of America Securities Remains a Buy on Meiragtx Holdings (MGTX)

TIPRANKS
·
Aug 14

MeiraGTx Gains; Reports over $200 Mln in License Revenue

Reuters
·
Aug 14

MeiraGTx Holdings PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Sector Update: Healthcare Stocks Advance Pre-Bell Thursday

MT Newswires Live
·
Aug 13

Shares of MeiraGTx Climb 7.1% Premarket After Q2 Revenue Beat

THOMSON REUTERS
·
Aug 13

MeiraGTx Posts Corporate Deck Highlighting Late-Stage Gene Therapy Pipeline, Riboswitch Platform

Reuters
·
Aug 13

MeiraGTx Q2 Revenue Jumps on Reogen License Revenue

Reuters
·
Aug 13

MeiraGTx Hldgs Q2 Sales $321.434M Beat $12.476M Estimate

Benzinga Earnings
·
Aug 13

Earnings Flash (MGTX) MeiraGTx Posts Q2 Net Income $1.71 a Share, vs. FactSet Est of $0.35 Loss

MT Newswires Live
·
Aug 13

MeiraGTx Q2 FY26 Net Income Swings to USD 160.7 Million; Revenue Jumps to USD 321.4 Million

Reuters
·
Aug 13

MeiraGTx Q2 Income from Operations USD 244.425 Million

THOMSON REUTERS
·
Aug 13

MeiraGTx Q2 EPS USD 1.71

THOMSON REUTERS
·
Aug 13

Corrected-MeiraGTx Q2 Revenue USD 321.4 Million VS. Ibes Estimate USD 12.5 Million (Corrects Amount)

THOMSON REUTERS
·
Aug 13

Graviton Bioscience Announces Clearance of Investigational New Drug (Ind) for Gv101 for the Treatment of Friedreich's Ataxia

THOMSON REUTERS
·
Aug 11